{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T19:31:47Z","timestamp":1776195107896,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.humimm.2016.02.006","type":"journal-article","created":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T09:24:38Z","timestamp":1456219478000},"page":"1063-1070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Donor-specific antibodies and liver transplantation"],"prefix":"10.1016","volume":"77","author":[{"given":"Arnaud","family":"Del Bello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Congy-Jolivet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Danjoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Muscari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nassim","family":"Kamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2016.02.006_b0005","first-page":"1465","article-title":"Significance of a positive crossmatch on outcome in human liver transplantation","volume":"24","author":"Ogura","year":"1992","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.humimm.2016.02.006_b0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1399-0012.1994.tb00956.x","article-title":"High one-month liver graft failure rates in flow-cytometry crossmatch-positive recipients","volume":"8","author":"Ogura","year":"1994","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0015","first-page":"396","article-title":"Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy","volume":"23","author":"Takaya","year":"1991","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.humimm.2016.02.006_b0020","unstructured":"OPTN\/SRTR 2012: Annual Data Report, 2012."},{"key":"10.1016\/j.humimm.2016.02.006_b0025","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/845040","article-title":"Clinical relevance of HLA antibody monitoring after kidney transplantation","author":"Morath","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.humimm.2016.02.006_b0030","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2016.02.006_b0035","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.healun.2013.08.011","article-title":"The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation","volume":"32","author":"Berry","year":"2013","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0040","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.healun.2013.07.004","article-title":"Acute antibody-mediated rejection after lung transplantation","volume":"32","author":"Witt","year":"2013","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40472-015-0061-x","article-title":"Diagnosis and treatment of pancreas rejection","volume":"2","author":"Redfield","year":"2015","journal-title":"Curr. Transplant. Rep."},{"key":"10.1016\/j.humimm.2016.02.006_b0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2016.02.006_b0055","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/01.TP.0000436927.08026.a8","article-title":"Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome","volume":"97","author":"Reinsmoen","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2016.02.006_b0060","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/TP.0b013e31818bd790","article-title":"Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies","volume":"87","author":"Alvarez-M\u00e1rquez","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2016.02.006_b0065","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(72)90288-7","article-title":"Immunopathological studies of orthotopic human liver allografts","volume":"7745","author":"Andres","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2016.02.006_b0070","first-page":"1383","article-title":"Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model","volume":"142","author":"Nakamura","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.humimm.2016.02.006_b0075","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00007890-198903000-00025","article-title":"Soluble HLA antigens in the circulation of liver graft recipients","volume":"47","author":"Davies","year":"1989","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2016.02.006_b0080","first-page":"51","article-title":"Analysis of sequential changes in major histocompatibility complex expression in human liver grafts after transplantation","volume":"12","author":"Steinhoff","year":"1988","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.humimm.2016.02.006_b0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1055\/s-2007-1007376","article-title":"Immunopathology of antibodies as effectors of orthotopic liver allograft rejection","volume":"12","author":"Demetris","year":"1992","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.humimm.2016.02.006_b0090","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/j.1600-6143.2008.02300.x","article-title":"New insights into mechanisms of spontaneous liver transplant tolerance: the role of Foxp3-expressing CD25+CD4+ regulatory T cells","volume":"8","author":"Li","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0095","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.4049\/jimmunol.158.10.4654","article-title":"Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction","volume":"158","author":"Qian","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2016.02.006_b0100","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0198-8859(00)00113-0","article-title":"CD28-CTLA-4 and CD80\/86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant","volume":"61","author":"Minguela","year":"2000","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2016.02.006_b0105","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0198-8859(97)00144-4","article-title":"HLA-DRB1 and -DQB1 polymorphism in liver recipients: relationship between HLA-DQB1\u22170302 allele frequency and acute rejection","volume":"56","author":"Muro","year":"1997","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2016.02.006_b0110","first-page":"1072","article-title":"Humoral rejection of rat hepatic transplants by passive transfer of serum","volume":"19","author":"Knechtle","year":"1987","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.humimm.2016.02.006_b0115","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00007890-198802000-00030","article-title":"Analysis of sequential changes in mayor histocompatibility complex expression in human liver grafts after transplantation","volume":"45","author":"Steinhoff","year":"1988","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2016.02.006_b0120","first-page":"8365","article-title":"Expression of HLA-DR antigens on bileduct cells of rejected liver transplant","volume":"1500","author":"Takacs","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2016.02.006_b0125","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/00007890-198511000-00007","article-title":"Induction of HLA-DR\/IA antigens in human liver allografts","volume":"40","author":"Demetris","year":"1985","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2016.02.006_b0130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00007890-198702000-00025","article-title":"Expression of major histocompatibility complex antigens and replacement of donor cells by recipient ones in human liver grafts","volume":"43","author":"Gouw","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2016.02.006_b0135","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/lt.23534","article-title":"Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts","volume":"18","author":"Miyagawa-Hayashino","year":"2012","journal-title":"Liver Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0140","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/ajt.12651","article-title":"Prevalence, incidence and risk factors for donor specific anti-HLA antibodies in maintenance liver transplant patients","volume":"14","author":"Del Bello","year":"2014","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0145","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/lt.20787","article-title":"The importance of CD25+ CD4+ regulatory T cells in mouse hepatic allograft tolerance","volume":"12","author":"Jiang","year":"2006","journal-title":"Liver Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0150","first-page":"2217","article-title":"Antibody-mediated rejection of human orthotopic liver allografts","volume":"21","author":"Demetris","year":"1989","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.humimm.2016.02.006_b0155","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1111\/j.1600-6143.2006.01554.x","article-title":"Isolated donor specific alloantibodies-mediated rejection after ABO compatible liver transplantation","volume":"6","author":"Watson","year":"2006","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0160","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/lt.23687","article-title":"Preformed class II donor-specific antibodies are associated with increased risk of early rejection after liver transplantation","volume":"19","author":"O\u2019Leary","year":"2013","journal-title":"Liver Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0165","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/lt.22233","article-title":"Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies","volume":"17","author":"Kozlowski","year":"2011","journal-title":"Liver Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0170","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/lt.23403","article-title":"Sinusoidal C4d deposits in liver allograft indicate an antibody mediated response: diagnostic considerations in the evaluation of liver allografts","volume":"6","author":"Kozlowski","year":"2012","journal-title":"Liver Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0175","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/tri.12654","article-title":"De novo donor-specific antibodies mediated rejection in liver transplant patients","volume":"28","author":"Del Bello","year":"2015","journal-title":"Transplant. Int."},{"key":"10.1016\/j.humimm.2016.02.006_b0180","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1399-0012.1989.tb00531.x","article-title":"Evidence for hyperacute rejection of human liver grafts: the case of the canary kidneys","volume":"3","author":"Starzl","year":"1989","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0185","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/lt.23707","article-title":"Pretransplant donor-specific anti-HLA antibodies as predictors of early allograft rejection in ABO-compatible liver transplantation","volume":"19","author":"Musat","year":"2013","journal-title":"Liver Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0190","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/lt.23788","article-title":"Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss","volume":"20","author":"O\u2019Leary","year":"2014","journal-title":"Liver Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0195","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/ajt.13153","article-title":"Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation","volume":"15","author":"O\u2019Leary","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0200","first-page":"489","article-title":"Antibody-mediated rejection of human orthotopic liver allografts","volume":"132","author":"Demetris","year":"1988","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.humimm.2016.02.006_b0205","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/lt.23948","article-title":"Acute liver allograft antibody-mediated rejection: an inter-institutional study of significant histopathological features","volume":"20","author":"O\u2019Leary","year":"2014","journal-title":"Liver Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0210","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1600-6143.2011.03786.x","article-title":"Re-examination of the lymphocytotoxic crossmatch in liver transplantation: can C4d stains help in monitoring?","volume":"12","author":"Lunz","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0215","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/MOT.0b013e328353584c","article-title":"Antibody-mediated rejection in the liver allograft","volume":"17","author":"Hubscher","year":"2012","journal-title":"Curr. Opin. Organ Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0220","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/lt.22323","article-title":"Complement C4d immunochemistry in the assessment of liver allograft biopsy samples: applications and pitfalls","volume":"17","author":"Bellamy","year":"2011","journal-title":"Liver Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0225","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/ajt.12667","article-title":"The role of donor-specific HLA alloantibodies in liver transplantation","volume":"14","author":"O\u2019Leary","year":"2014","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0230","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1600-6143.2010.03414.x","article-title":"The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation","volume":"11","author":"Musat","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0235","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.1840160310","article-title":"A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies","volume":"16","author":"Demetris","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.humimm.2016.02.006_b0240","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1111\/j.1600-6143.2012.04126.x","article-title":"Bortezomib for acute antibody-mediated rejection in liver transplantation","volume":"12","author":"Paterno","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0245","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/j.1600-6143.2011.03593.x","article-title":"High mean fluorescence intensity donor specific anti-HLA antibodies associated with chronic rejection postliver transplant","volume":"11","author":"O\u2019Leary","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0250","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/lt.23451","article-title":"Donor-specific human leucocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation","volume":"8","author":"Kaneku","year":"2012","journal-title":"Liver Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0255","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.3748\/wjg.15.3426","article-title":"Early plasmapheresis and rituximab for acute humoral rejection after ABO-compatible liver transplantation","volume":"15","author":"Kamar","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.humimm.2016.02.006_b0260","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/01.tp.0000229939.85412.27","article-title":"Late humoral rejection in a compliant ABO-compatible liver transplant recipient","volume":"82","author":"Wilson","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2016.02.006_b0265","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/ajt.13476","article-title":"Proposed diagnostic criteria for chronic antibody-mediated rejection in liver allografts","volume":"16","author":"O\u2019Leary","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0270","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/lt.23534","article-title":"Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts","volume":"11","author":"Miyagawa-Hayashino","year":"2012","journal-title":"Liver Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0275","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/lt.23854","article-title":"Donor-specific alloantibodies are associated with fibrosis progression after liver transplantation in hepatitis C virus-infected patients","volume":"20","author":"O\u2019Leary","year":"2014","journal-title":"Liver Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0280","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/lt.21509","article-title":"Biliary strictures following liver transplantation","volume":"14","author":"Sharma","year":"2008","journal-title":"Liver Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0285","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1478-3231.2012.02810.x","article-title":"Genetic, immunological and clinical risk factors for biliary strictures following liver transplantation","volume":"32","author":"Iacob","year":"2012","journal-title":"Liver Int."},{"key":"10.1016\/j.humimm.2016.02.006_b0290","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/lt.21408","article-title":"Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility","volume":"14","author":"Castillo-Rama","year":"2008","journal-title":"Liver Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0295","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.trim.2005.03.013","article-title":"Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: experience of one centre","volume":"14","author":"Muro","year":"2005","journal-title":"Transplant. Immunol."},{"key":"10.1016\/j.humimm.2016.02.006_b0300","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1432-2277.2009.01022.x","article-title":"Prevalence of anti-HLA antibodies after liver transplantation","volume":"23","author":"Fontana","year":"2010","journal-title":"Transplant. Int."},{"key":"10.1016\/j.humimm.2016.02.006_b0305","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/j.1600-6143.2012.03995.x","article-title":"Prevalence, course and impact of HLA donor-specific antibodies in liver transplantation in the first year","volume":"12","author":"Taner","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0310","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/ajt.12212","article-title":"De novo donor-specific HLA antibodies decrease patients and graft survival in liver transplant recipients","volume":"13","author":"Kaneku","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2016.02.006_b0315","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1 receptor activating antibodies in renal transplantation","volume":"352","author":"Dragun","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2016.02.006_b0320","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.hepres.2006.07.003","article-title":"Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development","volume":"36","author":"Yoshiji","year":"2006","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.humimm.2016.02.006_b0325","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/sj.bjp.0705339","article-title":"An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells","volume":"139","author":"Kurikawa","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.humimm.2016.02.006_b0330","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/TP.0000000000000185","article-title":"Association of anti-human leukocyte antigen and anti-angiotensin II type 1 receptor antibodies with liver allograft fibrosis after immunosuppression withdrawal","volume":"98","author":"Ohe","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2016.02.006_b0335","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2249.2001.01682.x","article-title":"Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation","volume":"126","author":"Aguilera","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2016.02.006_b0340","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.humimm.2006.02.010","article-title":"Intracellular expression of MICA in activated CD4 T lymphocytes and protection from NK cell-mediated MICA-dependent cytotoxicity","volume":"67","author":"Molinero","year":"2006","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2016.02.006_b0345","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.humimm.2006.02.017","article-title":"Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry","volume":"67","author":"Zou","year":"2006","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2016.02.006_b0350","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00251-008-0344-9","article-title":"Polymorphisms of MICA recognized by human alloantibodies","volume":"61","author":"Zou","year":"2009","journal-title":"Immunogenetics"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885916300039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885916300039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T13:40:51Z","timestamp":1748785251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885916300039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":70,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0198885916300039"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2016.02.006","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Donor-specific antibodies and liver transplantation","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2016.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}